
Stephen Daniel Wiviott MD
Adult Congenital Heart Disease
Assistant Professor of Medicine, Brigham and Women's Hospital
Join to View Full Profile
75 Longwood AvenueCardiovascular Division Brigham And Women's HospitalBoston, MA 02115
Phone+1 617-278-0145
Fax+1 617-734-7329
Dr. Wiviott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1999 - 2003
- Mass General Brigham/Brigham and Women's HospitalChief Residency, Internal Medicine, 2001 - 2002
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 1999
- Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
- Harvard Medical SchoolClass of 1996
Certifications & Licensure
- MA State Medical License 1998 - 2025
- MD State Medical License 2000 - 2001
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities.Douglas P Loesch, Manik Garg, Dorota Matelska, Dimitrios Vitsios, Xiao Jiang
Nature Communications. 2025-03-03 - Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers.Filipe A Moura, Frederick K Kamanu, Stephen D Wiviott, Robert P Giugliano, Miriam S Udler
Diabetes, Obesity & Metabolism. 2025-03-01 - 6 citationsAbelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.Christian T Ruff, Siddharth M Patel, Robert P Giugliano, David A Morrow, Bruce Hug
The New England Journal of Medicine. 2025-01-23
Journal Articles
- Association of Hospital-Level Differences in Care with Outcomes Among Patients with Acute ST-Segment Elevation Myocardial Infarction in ChinaXuan Zhang, Hui Sun, Marc S Sabatine, Stephen D Wiviott, JAMA Network Open
- Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesNicholas A Marston, Marc P Bonaca, Petr Jarolim, Deepak L Bhatt, Stephen D Wiviott, Eugene Braunwald, Marc S Sabatine, JAMA Cardiology
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesStephen D Wiviott, Marc S Sabatine, Christian T Ruff, Marc P Bonaca, Deepak L Bhatt, Darren K McGuire, The New England Journal of Medicine
- Join now to see all
Authored Content
- Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesAugust 2020
- Rivaroxaban and Post-Stroke Neurological Outcomes in Patients with Acute Coronary SyndromeFebruary 2018
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
- Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational StudyAugust 8th, 2024
- Potent Antiplatelet Not a Good Idea for Moderate COVID-19November 16th, 2021
- Anti-Arrhythmic Effects of SGLT2 Inhibitors May Be an Alias for Improving Heart FailureSeptember 11th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: